Antiphospholipid Syndrome in Obstetrics
Authors:
- Lothar HeilmannLHLothar Heilmann
- Georg-Friedrich V. TempelhoffGTGeorg-Friedrich V. Tempelhoff
- 1 April 2003
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 9 (2) , 143-150
Abstract
Antiphospholipid syndrome (APLS) in pregnancy is characterized by the presence of autoantibodies in association with recurrent fetal loss and severe complications such as preeclampsia, fetal growth retardation, or placental insufficiency. The most clinically important serologic markers are lupus anticoagulant, anticardiolipin antibodies, and recently anti-beta-2-glycoprotein 1 antibodies. At present, standardization does not exist and a definitive association between specific clinical manifestation and antibody level is not yet known. Experimental data gave evidence that passive transfer of antiphospholipid antibodies result in clinical manifestation of APLS, that is, fetal loss and thrombocytopenia. Treatment with heparin, aspirin, or intravenous immunoglobulins decreased the fetal loss rate. Treatment regimens in human are very difficult to interpret. Evidence from two prospective studies supported treatment with heparin and aspirin to improve pregnancy outcome. The risk of preeclampsia and placental insufficiency was substantial and occurred in 50% of patients. The general failure rate of heparin/aspirin treatment is approximately 30%. In such cases intravenous immunoglobulin in combination with heparin and aspirin has been used to treat APLS.Keywords
This publication has 42 references indexed in Scilit:
- The Influence of Antiphospholipid Antibodies on the Pregnancy Outcome of Patients With Recurrent Spontaneous AbortionClinical and Applied Thrombosis/Hemostasis, 2001
- Obstetric uses of intravenous immunoglobulin: Successes, failures, and promises☆☆☆★Journal of Allergy and Clinical Immunology, 2001
- State-of-the-Art Review: Antiphospholipid Thrombosis SyndromesClinical and Applied Thrombosis/Hemostasis, 2001
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Antiphospholipid Antibodies in Eclamptic WomenGynecologic and Obstetric Investigation, 1998
- Prospective Studies of the Association Between Anticardiolipin Antibody and Outcome of PregnancyObstetrics & Gynecology, 1995
- Normal fetal growth in women with antiphospholipid syndrome treated with high‐dose intravenous immunoglobulin (IVIG)Prenatal Diagnosis, 1995
- Poor Pregnancy Outcome and Anticardiolipin AntibodiesFetal Diagnosis and Therapy, 1994
- Antiphospholipid Antibodies in PregnancyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1992
- Prevention of Miscarriage in Antiphospholipid SyndromeAutoimmunity, 1992